Diseases, Conditions, Syndromes

Researchers advance treatment of tuberculosis by targeting new enzyme

Researchers at Johns Hopkins report they have laid the foundation to develop novel antibiotics that work against incurable, antibiotic-resistant bacteria like tuberculosis by targeting an enzyme essential to the production ...

Immunology

Groundbreaking immune approach targets humans instead of bacteria

Staphylococcal and streptococcal infections affect millions of individuals each year. They are a leading cause of sepsis and account for many cases of pneumonia and post-surgical infections. Despite the urgency of this situation, ...

Medical research

A new angle for countering severe bacterial infections and sepsis

Bacterial infections that don't respond to antibiotics are of rising concern, as is sepsis—the immune system's last-ditch, failed attack on infection that ends up being lethal itself. Reporting online in Nature on July ...

Diseases, Conditions, Syndromes

New hope in the fight against tuberculosis

According to figures of the World Health Organization, some 8.7 million people contracted tuberculosis in 2012 and this disease is fatal for approximately 1.3 million people throughout the world each year. One of the main ...

Genetics

Genome sequencing of MRSA infection predicts disease severity

The spread of the antibiotic-resistant pathogen MRSA (methicillin-resistant Staphylococcus aureus) remains a concerning public health problem, especially among doctors trying to determine appropriate treatment options for ...

page 5 from 17